A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

Clinical trial NCT07061574 · RECRUITING

Trial details

NCT number: NCT07061574
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes New Onset

Start date: 2026-03-10
Primary completion: 2030-04-15
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.